Similarly, both selective and non-selective A2AR antagonists (istradefylline and caffeine, respectively) exerted neuroprotective effects and improved motor activity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD [65,66]. The gene discussed is ADORA2A; the disease is Parkinson disease.